Logo-jnp
Original Article

1. Oxford-MEST classification in IgA nephropathy patients: A report from Iran
Hamid Nasri*, Mojgan Mortazavi, Ali Ghorbani, Heshmatollah Shahbazian, Soleiman Kheiri, Azar Baradaran, Afsoon Emami-Naieni, Maryam Saffari, Saeed Mardani, Ali Momeni, Yahya Madihi, Milad Baradaran-Ghahfarokhi, Mahmoud Rafieian-Kopaie, Parin Hedayati, Shahzad Baradaran, Mohammadreza Ardalan, Shahram Sajjadieh, Naziheh Assarzadegan, Seyed Mohammad Ahmadi Soleimani, Mohamad Reza Tamadon
J Nephropathol. 2012;1(1): 31-42. doi: 10.5812/jnp.7
PMCID: PMC3886168     PMID: 24475384     Scopus ID: 84867271251    
Article
PDF
XML
Cited By:
51
21
16
Original Article

2. Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
Fatemeh Hayati, Heshmatollah Shahbazian, Ali Ghorbani, Shahla Ahmadi Halili*, Eisa Rezaei, Leila Sabetnia, Seyed Seifollah Beladi Mousavi
J Nephropathol. 2019;8(2): e12. doi: 10.15171/jnp.2019.12
Scopus ID: 85065879302    
Article
PDF
XML
Cited By:
1
1
Original Article

3. Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobulin and standard therapy in kidney transplantation; a randomized double-blind clinical trial
Heshmatollah Shahbazian ORCID, Ali Ghorbani, Fatemeh Hayati, Seyed Seifollah Beladi Mousavi ORCID, Leila Sabetnia* ORCID, Shahla Ahmadi Halili, Shokouh Shayanpour ORCID, Isa Rezaee
J Nephropathol. 2020;9(1): e08. doi: 10.15171/jnp.2020.08
Scopus ID: 85078280329    
Article
PDF
XML
Cited By:
3
2
Original Article

4. Evaluation of mortality of COVID-19 patients with acute kidney injury (AKI) in comparison to the non-AKI patients
Heshmatollah Shahbazian ORCID, Mina Tafazoli* ORCID, Leila Sabet Nia ORCID, Ali Ghorbani ORCID, Shahla Ahmadi Halili ORCID, Fatemeh Jahangiri Mehr ORCID
J Nephropathol. 2023;12(1): e18376. doi: 10.34172/jnp.2022.18376
Scopus ID: 85148909263    
Article
PDF
XML
Cited By:
0
0